PDCD1 and gastric cancer: Kamada et al. (185) found that in patients and mice with advanced gastric cancer, anti-PD-1 mAb increased the proliferation of FoxP3highCD45RA−CD4+PD-1+T cells [effector Treg (eTreg) cells], which could suppress antitumor immunity.